Leach v. Pharmedoc Inc

CourtDistrict Court, W.D. Oklahoma
DecidedJune 12, 2019
Docket5:16-cv-01034
StatusUnknown

This text of Leach v. Pharmedoc Inc (Leach v. Pharmedoc Inc) is published on Counsel Stack Legal Research, covering District Court, W.D. Oklahoma primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Leach v. Pharmedoc Inc, (W.D. Okla. 2019).

Opinion

IN THE UNITED STATES DISTRICT COURT FOR THE WESTERN DISTRICT OF OKLAHOMA

JAMIE S. LEACH, and ) LEACHCO, INC. ) ) Plaintiffs, ) ) v. ) Case No. CIV-16-1034-SLP ) PHARMEDOC, INC. ) ) Defendant. ) O R D E R Before the Court are the parties’ claim construction briefing [Doc. Nos. 75-79] and a Joint Claim Construction and Pre-Hearing Statement [Doc. No. 72] which includes a claim construction chart. See Chart [Doc. No. 72-1].1 The parties identify eight terms for claim construction which the Court addresses below. I. Background Plaintiffs allege Defendant has infringed Plaintiffs’ U.S. Patent No. 6,499,164 for the Snoogle®, a J-shaped, full-body, pregnancy pillow (the ‘164 Patent). The ‘164 Patent is entitled BODY PILLOW WITH HORSESHOE-SHAPED TOP AND J-SHAPED BOTTOM. Plaintiff Jamie S. Leach invented the ‘164 Patent.2 Plaintiff Leachco, Inc. (Leachco) is the sole licensee of the ‘164 Patent.

1 Citations to the parties’ submissions reference the Court’s ECF pagination.

2 The Court recognizes that Plaintiff, Jamie S. Leach, is the owner of the ‘ 164 Patent. In Plaintiffs submissions to the Court, when addressing the prosecution history, Plaintiffs reference actions taken on behalf of Ms. Leach by her patent attorney and refer to her attorney as “Applicant’s Attorney.” For ease of reference, however, the Court simply refers to “Plaintiffs” throughout this The Court has conducted a claim construction hearing3 and heard argument of counsel. The parties did not present any expert testimony and agree no such testimony is needed for claim construction.

Each of the terms disputed by the parties appear in Claim 1 of the ‘164 Patent. Claim 1 provides: 1. A body pillow having a top which is essentially in the shape of a horseshoe[1] for accommodating an upper end of a person and a bottom which is essentially in the shape of a J[2] for accommodating a lower end of the person, a substantially cylindrical straight portion[3] connecting the horseshoe-shaped top[1] with the J-shaped bottom[2], the cross-sectional diameter of the body pillow[7] being between 7 and 12 inches, the horseshoe shaped top constituting[8] a semi-toroidal member[4] having a diameter of about 25 to 26 inches[5] and terminating in a foot spaced from the straight portion extending parallel to the straight portion and forming therewith a curved opening[6].

See ‘164 Patent, 6:8-17. Each term of Claim 1 disputed by the parties is designated by [ _ ] and numbered in the manner as designated by the parties. II. Legal Standards A. Claim Construction The claims of a patent define, in technical terms, the scope of protection conferred by the patent, i.e., the claims define the patentee’s invention to which the patentee is entitled the right to exclude. See Markman, 517 U.S. at 373 (“[A] patent must describe the exact scope of an invention and its manufacture to secure to the patentee all to which

Order without distinguishing actions taken by the patent attorney or Ms. Leach as the owner of the ‘164 Patent.

3 See Markman v. Westview Instrs., Inc. 517 U.S. 370, 373 (1996). he is entitled, and to apprise the public of what is still open to them.” (internal quotations, alterations and citation omitted)); Innova / Pure Water, Inc. v. Safari Water Filtration Sys., Inc., 381 F.3d 1111, 1115 (Fed. Cir. 2004) (“It is a bedrock principle of patent law that the

claims of a patent define the invention to which the patentee is entitled the right to exclude.”). Claim construction is a question of law for the court. Markman, 517 U.S. at 384. The court need only construe claims that are “in controversy” and only “to the extent necessary to resolve the controversy.” Vivid Techs, Inc. v. Am. Sci. & Eng’g, Inc., 200 F.3d

795, 803 (Fed. Cir. 1999). “A determination that a claim term ‘needs no construction’ or has the ‘plain and ordinary meaning’ may be inadequate when a term has more than one ‘ordinary’ meaning or when reliance on a term’s ‘ordinary’ meaning does not resolve the parties’ dispute” – for example, when the scope of what is covered by the term remains in dispute notwithstanding the ordinary meaning of the term. O2 Micro Int’l, Ltd. v. Beyond

Innovation Tech. Co., Ltd., 521 F.3d 1351, 1361 (Fed. Cir. 2008). Ultimately, “[t]he construction that stays true to the claim language and most naturally aligns with the patent’s description of the invention will be, in the end, the correct construction.” Reinshaw PLC v. Marposs Societa’ per Azioni, 158 F.3d 1243, 1250 (Fed. Cir. 1998). B. Sources for Construing Claims

A court considers three primary sources, referred to as “intrinsic evidence,” and often this evidence alone resolves any ambiguity as to a disputed claim term: (1) the language of the claims; (2) the specification (or written description); and (3) the prosecution history. Vitronics Corp. v. Conceptronic, Inc., 90 F.3d 1576, 1583 (Fed. Cir. 1996). When intrinsic evidence is insufficient to enable the court to determine the meaning of disputed claims, a court may also consider extrinsic evidence. Id. at 1584. “Extrinsic evidence is that evidence which is external to the patent and file history, such as expert

testimony, inventor testimony, dictionaries, and technical treatises and articles.” Id. 1. Intrinsic Evidence a. Claim Language Claim terms are usually given their ordinary and customary meaning – “the meaning that the term would have to a person of ordinary skill in the art [POSITA] at the time of

the invention, i.e., as of the effective filing date of the patent.” Phillips v. AWH Corp., 415 F.3d 1303, 1312 (Fed. Cir. 2005). This “objective baseline” is the starting point for claim construction. Id. at 1313. A POSITA reads the claim term in the context of the particular claim in which the disputed term appears, but also in the context of the patent as a whole including the patent specification and the prosecution history. Id.4

b. The Specification Next, the court looks at a patent’s specification as “[c]laims must be read in view of the specification, of which they are a part. Markman v. Westview Instrs., Inc., 52 F.3d 967, 979 (Fed. Cir. 1995) (en banc), aff’d 517 U.S. 370. “Usually, [the specification] is the single best guide to the meaning of a disputed term.” Howmedica Osteonics Corp. v.

Zimmer, Inc., 822 F.3d 1312, 1321 (Fed. Cir. 2016) (quotation marks and citation omitted).

4 As Plaintiffs state, “neither party has yet put forth a definition of the POSITA to this Court . . .” Pls.’ Resp. at 9. But “there is a fine line between reading a claim in light of the written description and reading a limitation into the claim from the written description.” Id. (citation omitted). If a patentee selects a meaning distinct from that which the claim terms would otherwise have

to a POSITA, the different meaning must be set forth in the specification in a manner sufficient to give one of ordinary skill notice of the change from the usual meaning. Innova / Pure Water, Inc., 381 F.3d at 1117. c. Prosecution History Third, the court may consider the prosecution history, if, as here, it is in evidence.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Enzo Biochem, Inc. v. Applera Corp.
599 F.3d 1325 (Federal Circuit, 2010)
Haemonetics Corp. v. Baxter Healthcare Corp.
607 F.3d 776 (Federal Circuit, 2010)
Cohesive Technologies, Inc. v. Waters Corp.
543 F.3d 1351 (Federal Circuit, 2008)
Rhodia Chimie & Rhodia, Inc. v. PPG Industries Inc.
402 F.3d 1371 (Federal Circuit, 2005)
Autogiro Company of America v. The United States
384 F.2d 391 (Court of Claims, 1967)
Zmi Corporation v. Cardiac Resuscitator Corporation
844 F.2d 1576 (Federal Circuit, 1988)
Southwall Technologies, Inc. v. Cardinal Ig Company
54 F.3d 1570 (Federal Circuit, 1995)
Vitronics Corporation v. Conceptronic, Inc.
90 F.3d 1576 (Federal Circuit, 1996)
Comark Communications, Inc. v. Harris Corporation
156 F.3d 1182 (Federal Circuit, 1998)
Texas Digital Systems, Inc. v. Telegenix, Inc.
308 F.3d 1193 (Federal Circuit, 2002)
Halliburton Energy Services, Inc. v. M-I LLC
514 F.3d 1244 (Federal Circuit, 2008)

Cite This Page — Counsel Stack

Bluebook (online)
Leach v. Pharmedoc Inc, Counsel Stack Legal Research, https://law.counselstack.com/opinion/leach-v-pharmedoc-inc-okwd-2019.